Onex Makes Fresh Attempt to Sell $1 Billion Carestream
(Bloomberg) -- Onex Corp. is exploring a new sale process for medical imaging equipment maker Carestream Health Inc., according to people with knowledge of the matter, after several previous attempts to divest the business.
The Toronto-based buyout firm is working with advisers and is seeking at least $1 billion from a proposed divestment of Carestream, a former unit of Eastman Kodak Co., said the people, who asked not to be identified as the information is private.
A formal sale is expected to kick off later this year, and Onex has reached out to prospective buyers to gauge interest, the people said.
The firm has made two previous attempts to sell the asset since it acquired Eastman Kodak's health group for $2.4 billion in 2007, renaming it Carestream Health.
Onex was seeking suitors for Carestream in 2013, before calling off the sale, Reuters reported.
The Canadian buyout firm ran separate processes in 2017 to find buyers for Carestream's medical imaging business and its digital dental-equipment unit, people with knowledge of the matter told Bloomberg News at the time. Onex sold the dental business to funds managed by Clayton, Dubilier & Rice and CareCapital Advisors in the same year. The price was not disclosed.
Deliberations are at an early stage and details such as valuation could change, the people said. A representative for Onex didn't respond to requests for comment.
New York-based Carestream provides technology used in radiology and also serves industrial markets with high-quality images for aircraft inspection, assemblies, castings and forensics. The company has more than 6,000 employees globally, according to its website.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.